Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox®) or abobotulinumtoxinA (Dysport®) make a difference?
Publication date: 2014 Source:Yearbook of Urology, Volume 2014 Author(s): E.S. Rovner
Source: Yearbook of Urology - Category: Urology & Nephrology Source Type: research
More News: Botox | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Urology & Nephrology